Replimune (REPL) EBIT (2017 - 2026)
Replimune (REPL) reported EBIT of -$73.3 million for Q1 2026, up 7.55% on a YoY basis from -$68.2 million in Q1 2025, and down 2.05% sequentially from -$71.9 million in Q4 2025.
Replimune (REPL) EBIT (2017 - 2026) Analysis & Trends
Replimune (REPL) has 10 years of EBIT data on file, last reported at -$73.3 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 7.55% year-over-year to -$73.3 million; the trailing twelve-month figure through Mar 2026 stood at -$319.9 million (down 22.28% YoY), and the FY2026 full-year result was -$319.9 million, down 22.28% from the prior year.
- EBIT eased to -$73.3 million in Q1 2026, from -$71.9 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$32.0 million in Q1 2022 to a low of -$90.4 million in Q2 2025.
- A 5-year average of -$60.3 million and a median of -$58.8 million in 2024 frame the typical range for EBIT.
- Across the five-year window, EBIT slumped 65.67% in 2023 and grew 7.7% in 2024, its largest moves.
- Tracing REPL's EBIT over 5 years: stood at -$41.6 million in 2022, then slumped by 35.82% to -$56.5 million in 2023, then retreated by 16.77% to -$66.0 million in 2024, then dropped by 8.86% to -$71.9 million in 2025, then slipped by 2.05% to -$73.3 million in 2026.
- Business Quant data shows REPL's EBIT at -$73.3 million in Q1 2026, -$71.9 million in Q4 2025, and -$84.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | -73.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.34 Mn |
| Dec 31, 2025 | -71.87 Mn |
| Sep 30, 2025 | -84.29 Mn |
| Jun 30, 2025 | -90.42 Mn |
| Mar 31, 2025 | -79.33 Mn |
| Dec 31, 2024 | -66.02 Mn |
| Sep 30, 2024 | -58.92 Mn |
| Jun 30, 2024 | -57.37 Mn |
| Mar 31, 2024 | -58.76 Mn |
| Dec 31, 2023 | -56.54 Mn |
| Sep 30, 2023 | -63.83 Mn |
| Jun 30, 2023 | -55.65 Mn |
| Mar 31, 2023 | -53.00 Mn |
| Dec 31, 2022 | -41.63 Mn |
| Sep 30, 2022 | -41.58 Mn |
| Jun 30, 2022 | -40.88 Mn |
| Mar 31, 2022 | -31.99 Mn |
| Dec 31, 2021 | -29.70 Mn |
| Sep 30, 2021 | -29.25 Mn |
| Jun 30, 2021 | -27.38 Mn |